The goal of this clinical trial is to learn if dTMS targeting the ACC can be used to rapidly and effectively treat AN. A randomized controlled study design is adopted, in which patients with AN are divided into the CBT+dTMS treatment group and CBT+pseudostimulation group by 1:1 randomization, followed by a 6-week intervention and a half-year follow-up to clarify whether CBT combined with dTMS is superior to single CBT treatment for AN.
Female, aged 18-35 years, right handedness.
Above primary education.
Meet the diagnostic criteria of AN in DSM-V, and13.0 kg/m2 ≤ body mass index (BMI)<18.5 kg/m2.
No systemic nutritional therapy, psychiatric medication or any form of psychotherapy have been received within 1 month before enrollment.
Diagnosed with a DSM-5 disease other than anorexia nervosa, or at high risk of suicide, strong impulsive behavior as well as anti-social behavior.
With severe physical or cognitive impairment.
Not able to undergo MRI.
Considered unsuitable for enrollment in this clinical trial for other reasons.